Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Wolf
CEO | Chief Executive Officer | 60 | 09/06/08 |
Director of Finance/CFO | 56 | 24/09/19 | |
David Waldman
IRC | Investor Relations Contact | - | - |
George Peoples
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
BRD | Director/Board Member | 70 | 25/04/16 |
Jeff Wolf
CEO | Chief Executive Officer | 60 | 09/06/08 |
Edward Smith
BRD | Director/Board Member | 48 | 31/12/08 |
John Monahan
BRD | Director/Board Member | 77 | 31/10/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,664,869 | 92,825,739 ( 96.03 %) | 0 | 96.03 % |
Company contact information
Scorpius Holdings, Inc.
627 Davis Drive Suite 300
27560, Morrisville
+919 240 7133
http://ww.ir.scorpiusbiologics.comSector
1st Jan change | Capi. | |
---|---|---|
+6.87% | 72.01B | |
+30.80% | 10.39B | |
+40.84% | 5.26B | |
-18.53% | 4.64B | |
+12.65% | 3.7B | |
+27.58% | 2.3B | |
-39.96% | 1.8B | |
-45.87% | 1.7B | |
-0.50% | 1.64B |